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Although some hematopoietic cell types are known to respond to sex hormones, hematopoietic stem cells
(HSCs) are generally thought to function similarly in both sexes. Recently in Nature, Nakada et al. (2014)
show that HSCs respond to higher levels of estrogen in females, resulting in enhanced self-renewal and
increased erythropoiesis.Hematopoietic cells express estrogen re-
ceptors (ERs) in both females and males,
and estrogens and ERs regulate multiple
aspects of hematopoiesis and mature
immune function (Kovats et al., 2010). An
important question is whether the higher
levels of estrogens in females, particularly
during pregnancy, lead to sex differences
in hematopoiesis. Prior work showed
that high levels of estrogen in pregnant
mice deplete lymphoid-primed multipo-
tent progenitors (MPPs), thus decreasing
B lymphopoiesis (Medina et al., 2001);
in contrast, estradiol stimulates dendritic
cell differentiation of myeloid progeni-
tors (reviewed in Kovats et al., 2010).
However, the potential regulation of
HSCs by sex steroids has not been well
studied.
Using assays to detect cycling HSCs
(defined as lineage-negative Sca-1+ c-
kit+ [LSK] CD150+ CD48), including
in vivo BrdU labeling, Ki-67/propidium
iodide staining, and turnover of GFP-
linked histone H2B, Nakada et al.
(2014) show that HSCs divide more
frequently in females than in males. The
increased HSC self-renewal in females
is reproducible and leads to 10%
more BrdU-labeled HSCs after 10 days.
Female MPPs also show more frequent
divisions.
To determine if endogenous estradiol
drives the increased HSC cycling in fe-
males, Nakada et al. employ ovariectomy
and Anastrozole, an inhibitor of the
enzyme aromatase required for estradiol
biosynthesis. Both treatments reduce
HSC cycling to levels seen in males.
Exogenous estradiol, injected daily for
1 week and yielding serum estradiol levels
comparable to those in pregnancy,
increased HSC cycling in both femalesand males. Pregnancy also induced a sig-
nificant increase in HSC andMPP cycling.
The lower levels of estradiol in unma-
nipulated males are apparently insuffi-
cient to promote increased HSC cycling,
suggesting exquisite dose-dependent
regulation of HSC self-renewal by estra-
diol. Alternately, increased HSC division
may require a second synergistic signal
that is also present at lower levels in
males. HSCs do express low levels of pro-
gesterone receptor (PR), but injection of
progesterone or blockade of PRs with
RU486 does not alter HSC cycling.
Although androgens modulate lympho-
poiesis (Kovats et al., 2010), HSCs do
not express androgen receptors and their
cycling is not driven by testosterone in fe-
males or males. These findings may un-
derlie the superior engraftment observed
when human HSCs are transplanted into
female immunodeficient mice (Notta
et al., 2010).
Estradiol acts via two distinct recep-
tors, the ubiquitous ERa (encoded by
Esr1) and the more selectively expressed
ERb (Esr2). Nakada et al. show that female
and male HSCs express Esr1, but not
Esr2. ERa is necessary for the estradiol-
induced HSC division, as demonstrated
by injection of a selective agonist for
ERa and use of germline Esr1-deficient
mice. Deletion of a conditional ERa
allele in hematopoietic cells using Vav-
Cre and competitive adoptive transfer
experiments of ERa-deficient and wild-
type HSCs showed that HSC-intrinsic
ERa is required for increased HSC cycl-
ing in females or in response to ectopic
estradiol administration. Rigorous pheno-
typic definition of HSCs is a relatively
recent achievement, and this is the first
demonstration that HSCs express ERsCell Stem Cell 14and increase their self-renewing divisions
in response to estradiol.
Nakada et al. find that, in normal fe-
males, increased HSC and MPP cycling
does not augment their numbers in BM
or lead to elevated BM or spleen cellu-
larity. This unexpected result suggests
that the HSCs die more readily or are
mobilized to other tissues. However,
female HSCs and MPPs do not enter
apoptosis in increased numbers, and the
possible migration of HSCs to other
tissues was not investigated. A third
possibility is that estradiol influences
a fraction of dividing female HSCs to
rapidly progress to later developmental
stages. Indeed, Nakada et al. show that
normal female mice have an elevated
frequency of megakaryocyte-erythroid
progenitors (MEPs), but not other line-
age-restricted progenitors, suggesting
that the increased HSC cycling promotes
their progression to erythroid cells. This
finding is puzzling because prior work
shows that estradiol induces apoptosis
in erythroid cell precursors by inhibiting
GATA-1; however, it is possible that eryth-
ropoiesis is stimulated by the increased
apoptosis of BM Ter119+ cells observed
in females. Pregnancy is a distinct case
in that increased numbers of HSCs
are present in the BM and spleen, which
correlates with increases in spleen cellu-
larity, largely due to increased numbers
of Ter119+ cells, although the numbers
of Mac-1/Gr-1+ myeloid cells also are
elevated. High levels of the pregnancy-
specific estriol may promote this process.
LSKCD150+CD48HSCs are function-
ally heterogeneous (Copley et al., 2012).
An unanswered question is whether ERa
signaling promotes cycling of all HSC
subsets. One intriguing possibility is that, February 6, 2014 ª2014 Elsevier Inc. 137
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asymmetric self-renewal. In a recently
described pathway, HSCs asymmetrically
divide, yielding myeloid-restricted pro-
genitors that retain long-term repopulat-
ing activity but are lineage-committed
to megakaryocyte-erythroid cells (Yama-
moto et al., 2013). This mechanism
may support the increased demand for
erythropoiesis during pregnancy.
Alternately, estradiol may act on preex-
isting myeloid-biased HSCs to increase
their cell cycle entry and accelerate
differentiation into MEPs. Higher levels
of TGFb have been implicated in the regu-
lation of HSC quiescence and inhibition
of cycling of lymphoid-biased HSCs,
while lower amounts were shown to pro-
mote cycling and myeloid gene expres-
sion programs in myeloid-biased HSCs
(Challen et al., 2010). Notably, estradiol
inhibits TGFb signaling (Band and Laiho,
2011) and therefore may dampen TGFb
signaling to levels necessary to drive
myeloid-biased HSCs into cycle and
allow subsequent MEP differentiation.
HSC subsets likely arise due to
epigenetic modifications that instruct
lineage-specific gene expression pro-
grams (Copley et al., 2012). Chronic
exposure of HSCs to higher levels of
estradiol in females may promote spe-
cific pathways of HSC specialization
via ER-mediated epigenetic regulatory
mechanisms. Nakada et al. show that138 Cell Stem Cell 14, February 6, 2014 ª201HSCs isolated from mice exposed to
exogenous estradiol have enrichment of
cell cycle genes and genes harboring
a binding motif for the transcription
factor E2F1, which is itself regulated
by estradiol. Future experiments could
determine if an estradiol-induced gene
expression program is restricted to a
subset of HSCs or promotes MEP
differentiation.
A definitive property of HSCs is their
ability to give rise to long-term self-renew-
ing HSCs upon serial transplantation.
Although Nakada et al. did not demon-
strate if estradiol alters this property of
HSCs, an earlier report showed that rela-
tive to control mice, the LSK population
in estradiol-treated mice is less quiescent
and yields superior immune reconstitution
upon transplant to irradiated mice (Illing
et al., 2012). However, the estradiol-
exposed HSCs may become exhausted
sooner, since their serial transplant even-
tually leads to reduced numbers of granu-
locytes, although not lymphocytes.
Inflammatory signals including type I
IFN and Toll-like receptor ligands also
drive HSCs into cycle, but ultimately
lead to HSC exhaustion and promote a
myeloid bias of HSCs (Schuettpelz and
Link, 2013). It would be fascinating to
know if ER signaling in females acceler-
ates the inflammation-induced HSC
cycling and if this contributes to the
female bias in autoimmunity.4 Elsevier Inc.ACKNOWLEDGMENTS
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